Lu, H., Y. Yang, et al., TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2 -targeted monoc lonal antibody therapy . Clin Cancer Res, 2011. 17(21): p. 6742 -53. 10. Alshaker, H.A.